BE794964A - NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEM - Google Patents
NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEMInfo
- Publication number
- BE794964A BE794964A BE794964DA BE794964A BE 794964 A BE794964 A BE 794964A BE 794964D A BE794964D A BE 794964DA BE 794964 A BE794964 A BE 794964A
- Authority
- BE
- Belgium
- Prior art keywords
- hypotensing
- agents
- preparing
- new
- new hypotensing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22372372A | 1972-02-04 | 1972-02-04 | |
| US29145072A | 1972-09-22 | 1972-09-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE794964A true BE794964A (en) | 1973-08-02 |
Family
ID=26918072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE794964D BE794964A (en) | 1972-02-04 | NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEM |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5623994B2 (en) |
| AU (1) | AU475978B2 (en) |
| BE (1) | BE794964A (en) |
| CA (1) | CA1009652A (en) |
| DE (1) | DE2305575A1 (en) |
| FR (1) | FR2173988B1 (en) |
| GB (1) | GB1418822A (en) |
| HK (1) | HK15581A (en) |
| YU (2) | YU210773A (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE31617E (en) * | 1972-02-04 | 1984-06-26 | Bristol-Myers Company | Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones |
| NL7807507A (en) * | 1977-07-25 | 1979-01-29 | Hoffmann La Roche | TRICYCLICAL CONNECTIONS. |
| US4146718A (en) * | 1978-04-10 | 1979-03-27 | Bristol-Myers Company | Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides |
| CA1131631A (en) * | 1979-06-20 | 1982-09-14 | Madhukar S. Chodnekar | Quinazoline derivatives and pharmaceutical preparations |
| ZW16481A1 (en) * | 1980-08-15 | 1982-03-10 | Hoffmann La Roche | Novel imidazoquinazoline derivatives |
| JPS6028979A (en) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | Imidazoquinazoline compound |
| CA2113115A1 (en) * | 1991-07-29 | 1993-02-18 | Vlad E. Gregor | Quinazoline derivatives as acetylcholinesterase inhibitors |
| HU219864B (en) | 1994-08-09 | 2001-08-28 | Eisai Co., Ltd. | Cgmp-pde inhibitory fused pyridazine derivatives and use thereof |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US8304420B2 (en) | 2006-11-28 | 2012-11-06 | Shire Llc | Substituted quinazolines for reducing platelet count |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MX354786B (en) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS. |
| GB0808968D0 (en) * | 2008-05-16 | 2008-06-25 | Shire Llc | Substitute quinazolines |
| GB0808947D0 (en) * | 2008-05-16 | 2008-06-25 | Shire Llc | Substituted quinazolines |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US9580471B2 (en) | 2011-03-01 | 2017-02-28 | Synergy Pharmaceuticals, Inc. | Process of preparing guanylate cyclase C agonists |
| US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| JP6606491B2 (en) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | Ultra high purity agonist of guanylate cyclase C, method for producing and using the same |
| JP6694385B2 (en) | 2013-08-09 | 2020-05-13 | アーデリクス，インコーポレーテッド | Compounds and methods for inhibiting phosphate transport |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
| CN117062819A (en) * | 2021-03-23 | 2023-11-14 | 北京生命科学研究所 | Polycyclic compound and use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE760013A (en) * | 1969-12-18 | 1971-06-08 | Smith Kline French Lab | IMIDAZO AND PYRIMIDO - (2,1-B) QUINAZOLINES, THEIR PREPARATION PROCESSES AND PHARMACEUTICAL COMPOSITIONS CONTAINING |
-
0
- BE BE794964D patent/BE794964A/en not_active IP Right Cessation
-
1973
- 1973-02-01 AU AU51668/73A patent/AU475978B2/en not_active Expired
- 1973-02-02 CA CA162,747A patent/CA1009652A/en not_active Expired
- 1973-02-02 FR FR7303843A patent/FR2173988B1/fr not_active Expired
- 1973-02-02 GB GB539073A patent/GB1418822A/en not_active Expired
- 1973-02-02 JP JP1303873A patent/JPS5623994B2/ja not_active Expired
- 1973-02-05 DE DE19732305575 patent/DE2305575A1/en active Granted
- 1973-08-03 YU YU02107/73A patent/YU210773A/en unknown
-
1981
- 1981-04-23 HK HK155/81A patent/HK15581A/en unknown
- 1981-06-15 YU YU01510/81A patent/YU151081A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1009652A (en) | 1977-05-03 |
| YU210773A (en) | 1983-02-28 |
| HK15581A (en) | 1981-05-01 |
| DE2305575A1 (en) | 1973-08-09 |
| JPS5623994B2 (en) | 1981-06-03 |
| YU151081A (en) | 1983-12-31 |
| AU475978B2 (en) | 1976-09-09 |
| AU5166873A (en) | 1974-08-01 |
| JPS4886894A (en) | 1973-11-15 |
| GB1418822A (en) | 1975-12-24 |
| FR2173988A1 (en) | 1973-10-12 |
| DE2305575C2 (en) | 1989-01-12 |
| FR2173988B1 (en) | 1976-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE794964A (en) | NEW HYPOTENSING AGENTS AND METHOD FOR PREPARING THEM | |
| BE779203A (en) | 2-HYDROCARBYLDITHIO-5-MERCAPTO-1, 3, 4, -THIADIAZOLES AND METHOD FOR PREPARING THEM, | |
| BE799001A (en) | NEW BENZODIAZEPINES AND METHODS FOR PREPARING THEM | |
| BE799608A (en) | SUBSTITUTED DIAMINES, AND METHODS FOR PREPARING THEM | |
| BE758219A (en) | ANTIBACTERIAL AGENTS AND METHOD FOR PREPARING THEM | |
| BE790165A (en) | NEW AMINOALCANOLS AND PROCESS FOR PREPARING THEM | |
| BE804550A (en) | BENZOFURAN DERIVATIVES AND PROCESS FOR PREPARING THEM | |
| BE770531A (en) | 3-FORMYL-CEPHALOSPORINS AND METHOD FOR PREPARING THEM | |
| BE755884A (en) | POLYALKENAMERES AND PROCESS FOR PREPARING THEM | |
| BE808599A (en) | NEW PYRAZOLODIAZEPINES AND METHOD FOR PREPARING THEM | |
| BE793976A (en) | NEW POLYAMINES AND PROCESS FOR PREPARING THEM | |
| BE805047A (en) | ANTI-ARRHYTHMIC AGENTS AND METHOD FOR PREPARING THEM | |
| BE777246A (en) | NEW ANTIBIOTICS AND METHOD FOR PREPARING THEM | |
| BE811467A (en) | TRIPEPTIDES AND PROCESS FOR PREPARING THEM | |
| BE804350A (en) | ANTIBACTERIAL AGENTS AND METHOD FOR PREPARING THEM | |
| BE799139A (en) | ANTIBIOTIC DERIVATIVES AND PROCESS FOR PREPARING THEM | |
| BE794532A (en) | NEW 3-HYDROXYMETHYL-5-BENZYLIDENE-AZOLIDINONES AND PROCESS FOR MAKING THEM | |
| BE804251A (en) | ANTIBACTERIAL AGENTS AND METHOD FOR PREPARING THEM | |
| BE800635A (en) | ANTIBACTERIAL AGENTS AND METHOD FOR PREPARING THEM | |
| BE816452A (en) | NEW RADIOGRAPHIC CONTRAST AGENTS AND METHOD FOR PREPARING THEM | |
| BE799098A (en) | PYRAZOLE DERIVATIVES AND PROCESS FOR PREPARING THEM | |
| BE806416A (en) | NEW BINDERS AND PROCESS FOR PREPARING THEM | |
| BE802336A (en) | NEW HYDROXY-AMINOSTEROIDS AND PROCESS FOR THEIR PREPARATION | |
| BE791322A (en) | NEW 1-PHENYL-3-HYDROXY-3-METHYLTRIAZENES AND METHODS FOR MAKING THEM | |
| BE802727A (en) | NEW POLYVINYL COMPOUNDS AND PROCESS FOR PREPARING THEM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE20 | Patent expired |
Owner name: BRISTOL MYERS CY Effective date: 19930202 |